Literature DB >> 21876502

Interleukin-6 and verbal memory in recurrent major depressive disorder.

Rodrigo Grassi-Oliveira1, Moisés Evandro Bauer, Júlio Carlos Pezzi, Antonio Lucio Teixeira, Elisa Brietzke.   

Abstract

OBJECTIVE: To evaluate the possible association between peripheral levels of interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-alpha) with immediate and delayed verbal recall in a group of recurrent depressed women.
METHODS: Logical Memory Subtests of the Wechsler Memory Scale - Revised was administered to 30 patients with recurrent major depressive disorder with no clinical and psychiatric comorbidities. Blood samples were collected from 8:00 am to 9:00 am, before memory assessments.Plasma was stored and ELISA assay was used to detect IL-6 and TNF-alpha levels.
RESULTS: There was a statistically significant association between IL-6 levels and immediate verbal recall (IVR) (B=-0.787, p=0.000) and delayed verbal recall (DVR) (B=-0.695, p=0.001) even after controlling for age, depression severity and body mass index.
CONCLUSION: The results of this study indicated that low performances in IVR and DVR are associated with higher IL-6 levels in women with recurrent MDD. The results of this study suggest the existence of an association between inflammatory imbalance and cognitive impairment in MDD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21876502

Source DB:  PubMed          Journal:  Neuro Endocrinol Lett        ISSN: 0172-780X            Impact factor:   0.765


  16 in total

1.  Trajectories of peripheral interleukin-6, structure of the hippocampus, and cognitive impairment over 14 years in older adults.

Authors:  Andrea L Metti; Howard Aizenstein; Kristine Yaffe; Robert M Boudreau; Anne Newman; Lenore Launer; Peter J Gianaros; Oscar L Lopez; Judith Saxton; Diane G Ives; Stephen Kritchevsky; Abbe N Vallejo; Caterina Rosano
Journal:  Neurobiol Aging       Date:  2015-07-28       Impact factor: 4.673

Review 2.  Pre-treatment effects of peripheral tumors on brain and behavior: neuroinflammatory mechanisms in humans and rodents.

Authors:  Andrew Schrepf; Susan K Lutgendorf; Leah M Pyter
Journal:  Brain Behav Immun       Date:  2015-05-06       Impact factor: 7.217

3.  Measuring sickness behavior in the context of pancreatic cancer.

Authors:  Kristen Tobias; Barry Rosenfeld; Hayley Pessin; William Breitbart
Journal:  Med Hypotheses       Date:  2015-01-14       Impact factor: 1.538

4.  The relationship between immune and cognitive dysfunction in mood and psychotic disorder: a systematic review and a meta-analysis.

Authors:  M Morrens; C Overloop; V Coppens; E Loots; M Van Den Noortgate; S Vandenameele; M Leboyer; L De Picker
Journal:  Mol Psychiatry       Date:  2022-04-28       Impact factor: 15.992

5.  Cognitive impairment in rheumatoid arthritis: role of lymphocyte subsets, cytokines and neurotrophic factors.

Authors:  Laura E Petersen; Talita S A Baptista; Júlia K Molina; Julia G Motta; Aline do Prado; Deise M Piovesan; Tatiana de Nardi; Thiago W Viola; Érica L M Vieira; Antonio L Teixeira; Rodrigo Grassi-Oliveira; Moisés Evandro Bauer
Journal:  Clin Rheumatol       Date:  2018-01-25       Impact factor: 2.980

6.  The relationship between interleukin-1 receptor antagonist and cognitive function in older adults with bipolar disorder.

Authors:  Francis E Lotrich; Meryl A Butters; Howard Aizenstein; Megan M Marron; Charles F Reynolds; Ariel G Gildengers
Journal:  Int J Geriatr Psychiatry       Date:  2013-11-25       Impact factor: 3.485

7.  Investigating whether depressed youth exhibiting elevated C reactive protein perform worse on measures of executive functioning, verbal fluency and episodic memory in a large, population based sample of Dutch adolescents.

Authors:  Naoise Mac Giollabhui; Lauren B Alloy; Catharina A Hartman
Journal:  Brain Behav Immun       Date:  2020-09-02       Impact factor: 7.217

8.  Investigating whether a combination of higher CRP and depression is differentially associated with worse executive functioning in a cohort of 43,896 adults.

Authors:  Naoise Mac Giollabhui; Lauren B Alloy; Lizanne J S Schweren; Catharina A Hartman
Journal:  Brain Behav Immun       Date:  2021-05-27       Impact factor: 19.227

9.  Interleukin-6: the missing element of the neurocognitive deterioration in schizophrenia? The focus on genetic underpinnings, cognitive impairment and clinical manifestation.

Authors:  Dorota Frydecka; Błażej Misiak; Edyta Pawlak-Adamska; Lidia Karabon; Anna Tomkiewicz; Paweł Sedlaczek; Andrzej Kiejna; Jan Aleksander Beszłej
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-09-12       Impact factor: 5.270

10.  Brain immune interactions and air pollution: macrophage inhibitory factor (MIF), prion cellular protein (PrP(C)), Interleukin-6 (IL-6), interleukin 1 receptor antagonist (IL-1Ra), and interleukin-2 (IL-2) in cerebrospinal fluid and MIF in serum differentiate urban children exposed to severe vs. low air pollution.

Authors:  Lilian Calderón-Garcidueñas; Janet V Cross; Maricela Franco-Lira; Mariana Aragón-Flores; Michael Kavanaugh; Ricardo Torres-Jardón; Chih-Kai Chao; Charles Thompson; Jing Chang; Hongtu Zhu; Amedeo D'Angiulli
Journal:  Front Neurosci       Date:  2013-10-10       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.